Literature DB >> 29704665

Synthesis of multi-omic data and community metabolic models reveals insights into the role of hydrogen sulfide in colon cancer.

Vanessa L Hale1, Patricio Jeraldo2, Michael Mundy3, Janet Yao4, Gary Keeney5, Nancy Scott5, E Heidi Cheek5, Jennifer Davidson5, Megan Greene5, Christine Martinez5, John Lehman5, Chandra Pettry5, Erica Reed5, Kelly Lyke6, Bryan A White7, Christian Diener8, Osbaldo Resendis-Antonio9, Jaime Gransee10, Tumpa Dutta10, Xuan-Mai Petterson10, Lisa Boardman11, David Larson6, Heidi Nelson2, Nicholas Chia12.   

Abstract

Multi-omic data and genome-scale microbial metabolic models have allowed us to examine microbial communities, community function, and interactions in ways that were not available to us historically. Now, one of our biggest challenges is determining how to integrate data and maximize data potential. Our study demonstrates one way in which to test a hypothesis by combining multi-omic data and community metabolic models. Specifically, we assess hydrogen sulfide production in colorectal cancer based on stool, mucosa, and tissue samples collected on and off the tumor site within the same individuals. 16S rRNA microbial community and abundance data were used to select and inform the metabolic models. We then used MICOM, an open source platform, to track the metabolic flux of hydrogen sulfide through a defined microbial community that either represented on-tumor or off-tumor sample communities. We also performed targeted and untargeted metabolomics, and used the former to quantitatively evaluate our model predictions. A deeper look at the models identified several unexpected but feasible reactions, microbes, and microbial interactions involved in hydrogen sulfide production for which our 16S and metabolomic data could not account. These results will guide future in vitro, in vivo, and in silico tests to establish why hydrogen sulfide production is increased in tumor tissue.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29704665      PMCID: PMC6191348          DOI: 10.1016/j.ymeth.2018.04.024

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  76 in total

1.  NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model.

Authors:  Mitali Chattopadhyay; Ravinder Kodela; Kenneth R Olson; Khosrow Kashfi
Journal:  Biochem Biophys Res Commun       Date:  2012-02-16       Impact factor: 3.575

Review 2.  The gut microbiota, bacterial metabolites and colorectal cancer.

Authors:  Petra Louis; Georgina L Hold; Harry J Flint
Journal:  Nat Rev Microbiol       Date:  2014-09-08       Impact factor: 60.633

3.  Relating the metatranscriptome and metagenome of the human gut.

Authors:  Eric A Franzosa; Xochitl C Morgan; Nicola Segata; Levi Waldron; Joshua Reyes; Ashlee M Earl; Georgia Giannoukos; Matthew R Boylan; Dawn Ciulla; Dirk Gevers; Jacques Izard; Wendy S Garrett; Andrew T Chan; Curtis Huttenhower
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

4.  Hydrogen sulfide induces human colon cancer cell proliferation: role of Akt, ERK and p21.

Authors:  Wen-Jie Cai; Ming-Jie Wang; Li-Hua Ju; Cheng Wang; Yi-Chun Zhu
Journal:  Cell Biol Int       Date:  2010-04-14       Impact factor: 3.612

5.  Evidence that hydrogen sulfide is a genotoxic agent.

Authors:  Matias S Attene-Ramos; Elizabeth D Wagner; Michael J Plewa; H Rex Gaskins
Journal:  Mol Cancer Res       Date:  2006-01       Impact factor: 5.852

6.  Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes.

Authors:  Ian R Lanza; Shucha Zhang; Lawrence E Ward; Helen Karakelides; Daniel Raftery; K Sreekumaran Nair
Journal:  PLoS One       Date:  2010-05-10       Impact factor: 3.240

7.  The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients.

Authors:  Annemarie Boleij; Elizabeth M Hechenbleikner; Andrew C Goodwin; Ruchi Badani; Ellen M Stein; Mark G Lazarev; Brandon Ellis; Karen C Carroll; Emilia Albesiano; Elizabeth C Wick; Elizabeth A Platz; Drew M Pardoll; Cynthia L Sears
Journal:  Clin Infect Dis       Date:  2014-10-09       Impact factor: 9.079

8.  There may be more than meets the eye with Clostridium perfringens bacteremia.

Authors:  Stephen Melnick; Salik Nazir; Brian Chwiecko; Benjamin Lloyd
Journal:  J Community Hosp Intern Med Perspect       Date:  2017-06-06

9.  Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.

Authors:  Chamutal Gur; Yara Ibrahim; Batya Isaacson; Rachel Yamin; Jawad Abed; Moriya Gamliel; Jonatan Enk; Yotam Bar-On; Noah Stanietsky-Kaynan; Shunit Coppenhagen-Glazer; Noam Shussman; Gideon Almogy; Angelica Cuapio; Erhard Hofer; Dror Mevorach; Adi Tabib; Rona Ortenberg; Gal Markel; Karmela Miklić; Stipan Jonjic; Caitlin A Brennan; Wendy S Garrett; Gilad Bachrach; Ofer Mandelboim
Journal:  Immunity       Date:  2015-02-10       Impact factor: 31.745

Review 10.  Metabolic modeling with Big Data and the gut microbiome.

Authors:  Jaeyun Sung; Vanessa Hale; Annette C Merkel; Pan-Jun Kim; Nicholas Chia
Journal:  Appl Transl Genom       Date:  2016-02-05
View more
  16 in total

1.  Considerations When Designing a Microbiome Study: Implications for Nursing Science.

Authors:  Katherine A Maki; Ana F Diallo; Mark B Lockwood; Alexis T Franks; Stefan J Green; Paule V Joseph
Journal:  Biol Res Nurs       Date:  2018-11-08       Impact factor: 2.522

2.  Cognitive analysis of metabolomics data for systems biology.

Authors:  Erica L-W Majumder; Elizabeth M Billings; H Paul Benton; Richard L Martin; Amelia Palermo; Carlos Guijas; Markus M Rinschen; Xavier Domingo-Almenara; J Rafael Montenegro-Burke; Bradley A Tagtow; Robert S Plumb; Gary Siuzdak
Journal:  Nat Protoc       Date:  2021-01-22       Impact factor: 13.491

3.  The Role of H2S in the Gastrointestinal Tract and Microbiota.

Authors:  Ailin Xiao; Chuanyong Liu; Jingxin Li
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  The Unreasonable Effectiveness of Inverse Reinforcement Learning in Advancing Cancer Research.

Authors:  John Kalantari; Heidi Nelson; Nicholas Chia
Journal:  Proc Conf AAAI Artif Intell       Date:  2020-04-03

Review 5.  Computational Modeling of the Human Microbiome.

Authors:  Shomeek Chowdhury; Stephen S Fong
Journal:  Microorganisms       Date:  2020-01-31

6.  Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.

Authors:  Minsuk Kim; Emily Vogtmann; David A Ahlquist; Mary E Devens; John B Kisiel; William R Taylor; Bryan A White; Vanessa L Hale; Jaeyun Sung; Nicholas Chia; Rashmi Sinha; Jun Chen
Journal:  mBio       Date:  2020-02-18       Impact factor: 7.867

7.  A Comparative Evaluation of Tools to Predict Metabolite Profiles From Microbiome Sequencing Data.

Authors:  Xiaochen Yin; Tomer Altman; Erica Rutherford; Kiana A West; Yonggan Wu; Jinlyung Choi; Paul L Beck; Gilaad G Kaplan; Karim Dabbagh; Todd Z DeSantis; Shoko Iwai
Journal:  Front Microbiol       Date:  2020-12-04       Impact factor: 5.640

8.  Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers.

Authors:  Vanessa L Hale; Patricio Jeraldo; Jun Chen; Michael Mundy; Janet Yao; Sambhawa Priya; Gary Keeney; Kelly Lyke; Jason Ridlon; Bryan A White; Amy J French; Stephen N Thibodeau; Christian Diener; Osbaldo Resendis-Antonio; Jaime Gransee; Tumpa Dutta; Xuan-Mai Petterson; Jaeyun Sung; Ran Blekhman; Lisa Boardman; David Larson; Heidi Nelson; Nicholas Chia
Journal:  Genome Med       Date:  2018-10-31       Impact factor: 11.117

9.  Growth rate alterations of human colorectal cancer cells by 157 gut bacteria.

Authors:  Rahwa Taddese; Daniel R Garza; Lilian N Ruiter; Marien I de Jonge; Clara Belzer; Steven Aalvink; Iris D Nagtegaal; Bas E Dutilh; Annemarie Boleij
Journal:  Gut Microbes       Date:  2020-11-09

Review 10.  Cysteine metabolic circuitries: druggable targets in cancer.

Authors:  Vasco D B Bonifácio; Sofia A Pereira; Jacinta Serpa; João B Vicente
Journal:  Br J Cancer       Date:  2020-11-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.